MedTrace Logo

Femtosecond Laser for Cataract Surgery

NCT02110212 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2025-02-04

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and efficacy the OptiMedica Femtosecond Laser System, also known as the Catalys™ Precision Laser System, to perform two surgical maneuvers used in the treatment of subjects with cataracts. Efficacy will be evaluated by comparisons to the standard surgical procedure of continuous curvilinear capsulorhexis (CCC) and ultrasonic phacoemulsification.

Conditions

  • Cataract

Interventions

PROCEDURE

U/S Surgery and CCC

Subjects will receive the standard of care for U/S cataract surgery and CCC to facilitate removal of the crystalline lens.

DEVICE

FS Laser Surgery

The Catalys System is an ophthalmic surgical laser system intended for use in cataract surgery.

Sponsors & Collaborators

  • Abbott Medical Optics

    lead INDUSTRY

Principal Investigators

  • Juan F. Batlle, MD · Laser Center

  • William W. Culbertson, MD · Bascom Palmer Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-12-31
Completion
2014-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02110212 on ClinicalTrials.gov